Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Mylan Laboratories et al.
Current Parent CompanyViatris
Parent at the Time of the Penalty Announcement subscribe to see this data field
Recap of Ownership Changes subscribe to see this data field
Penalty: $108,000,000
Year: 2000
Date: November 29, 2000
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Mylan paid $100 million (plus $8 million in legal fees) to settle a price-fixing case alleging that it developed a plan to drastically increase prices on two of its generic drugs by cutting off its competitors' supply of the drugs' active ingredients. Mylan accomplished this by entering into long-term profit-sharing agreements with industry suppliers and distributors that gave Mylan the only reliable sources of the active ingredients. The three other defendants -- which apparently were not required to share in the settlement costs -- were New Jersey-based Cambrex Corporation, Italian pharmaceutical ingredient manufacturer Profarmaco S.r.l. (a subsidiary of Cambrex), and New York-based drug distributor Gyma. The settlement was also announced by the Federal Trade Commission (see separate entry).
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Court: District of the District of Columbia
Civil or Criminal Case: civil
Case ID: 1:98-cv-3115
Case Name: Connecticut v. Mylan Laboratories, Inc. (In re Lorazepam & Clorazepate Antitrust Litigation)
HQ Country of Current Parent: USA
HQ State of Current Parent: Pennsylvania
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Link to PACER Case Docket (must be logged in)(click here)
Link to Archived Court Document subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.